Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Effective Factors in Human-Specific Tropism and Viral Pathogenicity in Orthopoxviruses Publisher Pubmed



Ghabeshi S1, 2 ; Ghasemi S3 ; Mousavizadeh L4
Authors

Source: Cell Biology International Published:2023


Abstract

The orthopoxvirus (OPV) genus includes several species that infect humans, including variola, monkeypox, vaccinia, and cowpox. Variola and monkeypox are often life-threatening diseases, while vaccinia and cowpox are usually associated with local lesions. The epidemic potential for OPVs may be lower than respiratory-borne viruses or RNA viruses. However, OPVs are notable for their spread and distribution in different environments and among different hosts. The emergence or re-emergence of OPVs in the human population can also occur in wild or domestic animals as intermediate hosts. More effective and safer vaccines for poxvirus can be developed by understanding how immunity is regulated in poxvirus and vaccines for DNA viruses. Downstream events in cells affected by the virus are regulated functionally by a series of characteristics that are affected by host cell interactions and responses of cells against viral infections, including the interferon pathway and apoptosis. Furthermore, infection outcome is greatly influenced by the distinct selection of host-range and immune-modulatory genes that confer the potential for pathogenesis and host-to-host transmission and the distinct host-range properties of each immune-modulatory gene. The present study reviewed the effective factors in human-restricted tropism and virus pathogenicity in OPVs. © 2022 International Federation for Cell Biology.
Other Related Docs
4. Mechanisms of Immune Evasion of Monkeypox Virus, Frontiers in Microbiology (2023)
6. Poxviruses and the Immune System: Implications for Monkeypox Virus, International Immunopharmacology (2022)
11. D D a Strategies to Designing Chimeric Recombinant Vaccines, Journal of Applied Biotechnology Reports (2021)
13. Current Advances and Challenges in Mpox Vaccine Development: A Global Landscape, Therapeutic Advances in Vaccines and Immunotherapy (2025)
14. Plausible Reasons for the Resurgence of Mpox (Formerly Monkeypox): An Overview, Tropical Diseases# Travel Medicine and Vaccines (2023)
15. Monkeypox Virus Diagnosis and Laboratory Testing, Reviews in Medical Virology (2023)
18. Insights on Mpox Virus Infection Immunopathogenesis, Reviews in Medical Virology (2023)